VIAN Therapeutics
PrivateLast Round
Seed
Nov 24, 2024
Total Funding Raised
$1.28M
Company Overview
VIAN Therapeutics is a biotechnology company developing a topical antiangiogenic peptide drug, VIAN-c4551, for treating microvascular retinal diseases such as diabetic retinopathy and age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VIAN Therapeutics Comps
Public and private peers based on sector, stage, and business model.
VIAN Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 24, 2024 | ||||
| Pre Seed | Oct 26, 2023 |
VIAN Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IndieBio | Seed, Pre Seed |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
| Sand Hill Angels | Seed |
| SOSV | Pre Seed, Seed |
| California Life Sciences | Seed |
VIAN Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VIAN Therapeutics's valuation, stock price, and market status.
